Skip to main content

Kirske David

In the past year, 2 open-market sale filings worth $109.2K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$109.2K
2 filings
Net
−$109.2K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Kirske David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

XFOR X4 Pharmaceuticals, Inc

Chief Financial Officer2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 1, 2026 (view filing)4:23 PM ETJun 301 dayKirske DavidChief Financial OfficerSSale−8.54K$4.26−$36.4K−4.8%167.8K after
May 13, 2026 (view filing)May 121 dayKirske DavidChief Financial OfficerSSale−17.0K$4.29−$72.8K−8.8%176.3K after

CTIC Cti Biopharma Corp

EVP, Chief Financial Officer6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 3, 2023 (view filing)Dec 29, 2022-Jan 3, 20235 daysKirske DavidEVP, Chief Financial OfficerSSale−54.0K$6.01−$324.5K−75.9%17.1K after5 lots
Oct 6, 2022 (view filing)Oct 42 daysKirske DavidEVP, Chief Financial OfficerSSale−2.11K$6.26−$13.2K−11.1%16.9K after3 lots
Oct 3, 2022 (view filing)Sep 29-Oct 34 daysKirske DavidEVP, Chief Financial OfficerSSale−141.0K$6.05−$853.3K−89.3%16.9K after4 lots
Sep 20, 2022 (view filing)Sep 164 daysKirske DavidEVP, Chief Financial OfficerSSale−22.6K$6.02−$136.0K−57.2%16.9K after
Jun 17, 2022 (view filing)Jun 17Same dayKirske DavidEVP, Chief Financial OfficerSSale−60.0K$6.21−$372.5K−89.0%7.40K after2 lots
Jun 16, 2022 (view filing)Jun 142 daysKirske DavidEVP, Chief Financial OfficerSSale−10.0K$5.50−$55.0K−57.5%7.40K after